Research map: Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: genetic evidence from large-scale phenomic analyses

Back to the article

Papers in this map

  1. The UK Biobank resource with deep phenotyping and genomic data · Clare Bycroft · 2018 · 10126 citations · Cited by this paper
  2. Dynamic regulation of circulating endotrophin by changes in fat mass in humans · 2026 · Related
  3. The Physical Activity Guidelines for Americans · Katrina L. Piercy · 2018 · 9866 citations · Cited by this paper
  4. Cytochrome P450 2E1 deficiency alters hepatic mitochondria and impairs liver organoid formation · 2026 · Related
  5. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
  6. Metabolomic signatures of type 2 diabetes and mortality: Methodological considerations and unresolved questions · 2026 · Related
  7. Tirzepatide Once Weekly for the Treatment of Obesity · Ania M. Jastreboff · 2022 · 3661 citations · Cited by this paper
  8. STAU1 fine-tunes adipose thermogenesis by regulating Ucp1 mRNA stability · 2026 · Related
  9. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes · A. Michael Lincoff · 2023 · 3058 citations · Cited by this paper
  10. Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitis · 2026 · Related
  11. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 · Daniel J. Drucker · 2018 · 2131 citations · Cited by this paper
  12. The endogenous ghrelin antagonist, LEAP2, accelerates puberty onset in conditions of early obesity · 2026 · Related
  13. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes · Juan P. Frías · 2021 · 2036 citations · Cited by this paper
  14. Muscle-derived ANXA2 promotes hepatic steatosis by activating SREBP1c-mediated de novo lipogenesis · 2026 · Related
  15. Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans · Brian Finan · 2013 · 693 citations · Cited by this paper
  16. The effects of acute ketone monoester supplementation on brain insulin responsiveness and cognitive performance: Results of a randomized, double-blind, placebo-controlled crossover trial in older men with overweight · 2026 · Related
  17. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial · Stefano Del Prato · 2021 · 669 citations · Cited by this paper
  18. SGLT2 inhibitors and GLP-1 receptor agonists in atrial fibrillation treatment: Clinical evidence and mechanistic insights · 2026 · Related
  19. The Cardiovascular Biology of Glucagon-like Peptide-1 · Daniel J. Drucker · 2016 · 660 citations · Cited by this paper
  20. Data leakage and overadjustment bias in proteomic prediction models of mortality among cardiovascular-kidney-metabolic syndrome stage 0–3 · 2026 · Related
  21. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial · Rohit Seth Loomba · 2023 · 523 citations · Cited by this paper
  22. Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial · Helena W. Rodbard · 2019 · 464 citations · Cited by this paper
  23. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes · Mark L. Hartman · 2020 · 352 citations · Cited by this paper
  24. Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease · Sunil Bhandari · 2022 · 336 citations · Cited by this paper
  25. The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes · Juan P. Frías · 2017 · 325 citations · Cited by this paper
  26. Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring · Joshua D. Mitchell · 2018 · 324 citations · Cited by this paper
  27. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. · Jean‐Baptiste Roberge · 1993 · 265 citations · Cited by this paper
  28. Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 · Rola Hammoud · 2022 · 239 citations · Cited by this paper
  29. Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models · Elizabeth A. Killion · 2018 · 238 citations · Cited by this paper
  30. Metabolic Messengers: glucagon-like peptide 1 · Fiona Mary Gribble · 2021 · 197 citations · Cited by this paper
  31. Causal mediation analysis in the context of clinical research · Zhongheng Zhang · 2016 · 177 citations · Cited by this paper
  32. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study · Xue Li · 2019 · 175 citations · Cited by this paper
  33. Tirzepatide: First Approval · Yahiya Y. Syed · 2022 · 140 citations · Cited by this paper
  34. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms · Jonathan E. Campbell · 2020 · 132 citations · Cited by this paper
  35. Factorial Mendelian randomization: using genetic variants to assess interactions · Jessica M. B. Rees · 2019 · 113 citations · Cited by this paper
  36. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B · Grace Lai‐Hung Wong · 2018 · 106 citations · Cited by this paper
  37. Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment · Sine P. Schiellerup · 2019 · 105 citations · Cited by this paper
  38. Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition · Kentaro Kaneko · 2019 · 105 citations · Cited by this paper
  39. Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction · John R. Ussher · 2017 · 103 citations · Cited by this paper

Source: OpenAlex (CC0)